HIV Citation List: May 23 - June 5, 2014

PubMed citations

1. Synthesis and Biological Evaluation of Novel 2-Arylalkylthio-5-iodine-6-substituted-benzyl-pyrimidine-4(3H)-ones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. Zhang, L., X. Tang, Y. Cao, S. Wu, Y. Zhang, J. Zhao, Y. Guo, C. Tian, Z. Zhang, J. Liu, and X. Wang. Molecules, 2014. 19(6): p. 7104-7121. PMID[24886938].

[PubMed]. HIV_0523-060514.

2. Logeracemin A, an anti-HIV Daphniphyllum Alkaloid Dimer with a New Carbon Skeleton from Daphniphyllum longeracemosum. Xu, J.B., H. Zhang, L.S. Gan, Y.S. Han, M.A. Wainberg, and J.M. Yue. Journal of the American Chemical Society, 2014. 136(21): p. 7631-7633. PMID[24828017].

[PubMed]. HIV_0523-060514.

3. Structural Features and anti-HIV-1 Activity of Novel Polysaccharides from Red Algae Grateloupia longifolia and Grateloupia filicina. Wang, S.C., S.W. Bligh, S.S. Shi, Z.T. Wang, Z.B. Hu, J. Crowder, C. Branford-White, and C. Vella. International Journal of Biological Macromolecules, 2007. 41(4): p. 369-375. PMID[17602734].

[PubMed]. HIV_0523-060514.

4. Artificial Peptides Conjugated with Cholesterol and Pocket-specific Small Molecules Potently Inhibit Infection by Laboratory-adapted and Primary HIV-1 Isolates and Enfuvirtide-resistant HIV-1 Strains. Wang, C., W. Shi, L. Cai, L. Lu, F. Yu, Q. Wang, X. Jiang, X. Xu, K. Wang, L. Xu, S. Jiang, and K. Liu. The Journal of Antimicrobial Chemotherapy, 2014. 69(6): p. 1537-1545. PMID[24500189].

[PubMed]. HIV_0523-060514.

5. 2-Aminothiazolones as anti-HIV Agents That Act as gp120-CD4 Inhibitors. Tiberi, M., C. Tintori, E.R. Ceresola, R. Fazi, C. Zamperini, P. Calandro, L. Franchi, M. Selvaraj, L. Botta, M. Sampaolo, D. Saita, R. Ferrarese, M. Clementi, F. Canducci, and M. Botta. Antimicrobial Agents and Chemotherapy, 2014. 58(6): p. 3043-3052. PMID[24614386].

[PubMed]. HIV_0523-060514.

6. A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase. Sharma, A., A. Slaughter, N. Jena, L. Feng, J.J. Kessl, H.J. Fadel, N. Malani, F. Male, L. Wu, E. Poeschla, F.D. Bushman, J.R. Fuchs, and M. Kvaratskhelia. Plos Pathogens, 2014. 10(5): p. e1004171. PMID[24874515].

[PubMed]. HIV_0523-060514.

7. Cannabinoid Inhibits HIV-1 Tat-stimulated Adhesion of Human Monocyte-like Cells to Extracellular Matrix Proteins. Raborn, E.S., M. Jamerson, F. Marciano-Cabral, and G.A. Cabral. Life Sciences, 2014. 104(1-2): p. 15-23. PMID[24742657].

[PubMed]. HIV_0523-060514.

8. Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors with Novel Isosorbide-derived P2 Ligands. Qiu, X., G.D. Zhao, L.Q. Tang, and Z.P. Liu. Bioorganic & Medicinal Chemistry Letters, 2014. 24(11): p. 2465-2468. PMID[24767846].

[PubMed]. HIV_0523-060514.

9. Synthesis and Evaluation of Phosphorus Containing, Specific CDK9/CycT1 Inhibitors. Nemeth, G., Z. Greff, A. Sipos, Z. Varga, R. Szekely, M. Sebestyen, Z. Jaszay, S. Beni, Z. Nemes, J.L. Pirat, J.N. Volle, D. Virieux, A. Gyuris, K. Kelemenics, E. Ay, J. Minarovits, S. Szathmary, G. Keri, and L. Orfi. Journal of Medicinal Chemistry, 2014. 57(10): p. 3939-3965. PMID[24742150].

[PubMed]. HIV_0523-060514.

10. The Potential Molecular Targets of Marine Sulfated Polymannuroguluronate Interfering with HIV-1 Entry. Interaction between SPMG and HIV-1 rgp120 and CD4 Molecule. Meiyu, G., L. Fuchuan, X. Xianliang, L. Jing, Y. Zuowei, and G. Huashi. Antiviral research, 2003. 59(2): p. 127-135. PMID[12895696].

[PubMed]. HIV_0523-060514.

11. Anti-HIV-1 Tigliane Diterpenoids from Excoecaria acertiflia Didr. Huang, S.Z., X. Zhang, Q.Y. Ma, H. Peng, Y.T. Zheng, J.M. Hu, H.F. Dai, J. Zhou, and Y.X. Zhao. Fitoterapia, 2014. 95: p. 34-41. PMID[24613801].

[PubMed]. HIV_0523-060514.

12. Synthesis of New Anionic Carbosilane Dendrimers via Thiol-ene Chemistry and Their Antiviral Behaviour. Galan, M., J. Sanchez Rodriguez, J.L. Jimenez, M. Relloso, M. Maly, F.J. de la Mata, M.A. Munoz-Fernandez, and R. Gomez. Organic & Biomolecular Chemistry, 2014. 12(20): p. 3222-3237. PMID[24728319].

[PubMed]. HIV_0523-060514.

13. Preclinical Profile of BI 224436, a Novel HIV-1 Non-catalytic-site Integrase Inhibitor. Fenwick, C., M. Amad, M.D. Bailey, R. Bethell, M. Bos, P. Bonneau, M. Cordingley, R. Coulombe, J. Duan, P. Edwards, L.D. Fader, A.M. Faucher, M. Garneau, A. Jakalian, S. Kawai, L. Lamorte, S. LaPlante, L. Luo, S. Mason, M.A. Poupart, N. Rioux, P. Schroeder, B. Simoneau, S. Tremblay, Y. Tsantrizos, M. Witvrouw, and C. Yoakim. Antimicrobial Agents and Chemotherapy, 2014. 58(6): p. 3233-3244. PMID[24663024].

[PubMed]. HIV_0523-060514.

ISI Web of Knowledge Citations

14. Specific Reactivation of Latent HIV-1 with Designer Zinc-finger Transcription Factors Targeting the HIV-1 5'-LTR Promoter. Wang, P., X. Qu, X. Wang, X. Zhu, H. Zeng, H. Chen, and H. Zhu. Gene Therapy, 2014. 21(5): p. 490-495. ISI[000335620800005].

[WOS]. HIV_0523-060514.

15. Protease Inhibitors Are Effective at Inhibiting Cell-to-cell HIV-1 Transfer. Titanji, B.K., M. Aasa-Chapman, C. Jolly, and D. Pillay. Antiviral Therapy, 2013. 18: p. A68-A68. ISI[000335229500060].

[WOS]. HIV_0523-060514.

16. Use of Vaginal Rings Charged with Antiviral Drugs for Preventing HIV Infection in Women. Memmi, M., T. Bourlet, and B. Pozzetto. Future Virology, 2014. 9(3): p. 227-230. ISI[000335164100002].

[WOS]. HIV_0523-060514.

17. Structure and Antioxidant Activity of Polyphenols Derived from Propolis. Kurek-Gorecka, A., A. Rzepecka-Stojko, M. Gorecki, J. Stojko, M. Sosada, and G. Swierczek-Zieba. Molecules, 2014. 19(1): p. 78-101. ISI[000334420300006].

[WOS]. HIV_0523-060514.

18. Wikstroelide M Potently Inhibits HIV Replication by Targeting Reverse Transcriptase and Integrase Nuclear Translocation. Zhang, X., S.Z. Huang, W.G. Gu, L.M. Yang, H. Chen, C.B. Zheng, Y.X. Zhao, D.C. Wan, and Y.T. Zheng. Chinese Journal of Natural Medicines, 2014. 12(3): p. 186-193. ISI[000335125000005].

[WOS]. HIV_0523-060514.

19. Synthesis of Curdlan Derivatives Regioselectively Modified at C-6: O-(N)-Acylated 6-amino-6-deoxycurdlan. Zhang, R.R. and K.J. Edgar. Carbohydrate Polymers, 2014. 105: p. 161-168. ISI[000335289400021].

[WOS]. HIV_0523-060514.

20. Poligapolide, a PI3K/Akt Inhibitor in Immunodeficiency Virus Type 1 TAT-transduced CHEM5 Cells, Isolated from the Rhizome of Polygala tenuifolia. Yoo, S.Y., T.K.V. Le, J.J. Jeong, and D.H. Kim. Chemical & Pharmaceutical Bulletin, 2014. 62(5): p. 467-471. ISI[000335273800009].

[WOS]. HIV_0523-060514.

21. Interferon-induced HERC5 Is Evolving under Positive Selection and Inhibits HIV-1 Particle Production by a Novel Mechanism Targeting Rev/RRRE-dependent RNA Nuclear Export. Woods, M.W., J.G. Tong, S.K. Tom, P.A. Szabo, P.C. Cavanagh, J.D. Dikeakos, S.M.M. Haeryfar, and S.D. Barr. Retrovirology, 2014. 11: 27. ISI[000334806900001].

[WOS]. HIV_0523-060514.

22. Synthesis and Antiviral Evaluation of 4'-(1,2,3-Triazol-1-yl)thymidines. Vernekar, S.K.V., L. Qiu, J. Zacharias, R.J. Geraghty, and Z.Q. Wang. MedChemComm, 2014. 5(5): p. 603-608. ISI[000335011900007].

[WOS]. HIV_0523-060514.

23. Binding of N-substituted Pyrrole Derivatives to HIV-1 gp41. Song, K.Z., J. Bao, Y.M. Sun, and J.Z.H. Zhang. Journal of Theoretical & Computational Chemistry, 2014. 13(2): 1450018. ISI[000334735600010].

[WOS]. HIV_0523-060514.

24. Biological Evaluation and Molecular Modelling of Didanosine Derivative. Ravetti, S., C.A. De Candia, M.S. Gualdesi, S. Pampuro, G. Turk, M.A. Quevedo, and M.C. Brinon. MedChemComm, 2014. 5(5): p. 622-631. ISI[000335011900010].

[WOS]. HIV_0523-060514.

25. Synthesis and Biological Evaluation of 5'-O-Dicarboxylic Fatty Acyl Monoester Derivatives of anti-HIV Nucleoside Reverse Transcriptase Inhibitors. Pemmaraju, B., H.K. Agarwal, D. Oh, K.W. Buckheit, R.W. Buckheit, R. Tiwari, and K. Parang. Tetrahedron Letters, 2014. 55(12): p. 1983-1986. ISI[000334480700005].

[WOS]. HIV_0523-060514.

26. MIV-150-containing Intravaginal Rings Protect Macaque Vaginal Explants against SHIV-RT Infection. Ouattara, L.A., P. Barnable, P. Mawson, S. Seidor, T.M. Zydowsky, L. Kizima, A. Rodriguez, J.A. Fernandez-Romero, M.L. Cooney, K.D. Roberts, A. Gettie, J. Blanchard, M. Robbiani, and N. Teleshova. Antimicrobial Agents and Chemotherapy, 2014. 58(5): p. 2841-2848. ISI[000334364300042].

[WOS]. HIV_0523-060514.

27. Pharmacokinetics of a CCR5 Inhibitor in Rhesus Macaques Following Vaginal, Rectal and Oral Application. Malcolm, R.K., D. Lowry, P. Boyd, L. Geer, R.S. Veazey, L. Goldman, P.J. Klasse, R.J. Shattock, and J.P. Moore. Journal of Antimicrobial Chemotherapy, 2014. 69(5): p. 1325-1329. ISI[000334688400023].

[WOS]. HIV_0523-060514.

28. An Efficient Synthesis of New Khellactone-type Compounds Using Potassium Hydroxide as Catalyst via One-pot, Three-component Reaction. Karami, B., K. Eskandari, and S. Khodabakhshi. Journal of the Iranian Chemical Society, 2014. 11(3): p. 631-637. ISI[000334683100005].

[WOS]. HIV_0523-060514.

29. Discovery of Novel Inhibitors of HIV-1 Reverse Transcriptase through Virtual Screening of Experimental and Theoretical Ensembles. Ivetac, A., S.E. Swift, P.L. Boyer, A. Diaz, J. Naughton, J.A.T. Young, S.H. Hughes, and J.A. McCammon. Chemical Biology & Drug Design, 2014. 83(5): p. 521-531. ISI[000334857000002].

[WOS]. HIV_0523-060514.

30. Structural Optimization of Cyclic Sulfonamide Based Novel HIV-1 Protease Inhibitors to Picomolar Affinities Guided by X-ray Crystallographic Analysis. Ganguly, A.K., S.S. Alluri, C.H. Wang, A. Antropow, A. White, D. Caroccia, D. Biswas, E. Kang, L.K. Zhang, S.S. Carroll, C. Burlein, J. Fay, P. Orth, and C. Strickland. Tetrahedron, 2014. 70(18): p. 2894-2904. ISI[000334972900003].

[WOS]. HIV_0523-060514.

31. Modified Silicone Elastomer Vaginal Gels for Sustained Release of Antiretroviral HIV Microbicides. Forbes, C.J., C.F. McCoy, D.J. Murphy, A.D. Woolfson, J.P. Moore, A. Evans, R.J. Shattock, and R.K. Malcolm. Journal of Pharmaceutical Sciences, 2014. 103(5): p. 1422-1432. ISI[000334162700011].

[WOS]. HIV_0523-060514.

32. Structure-based Design, Synthesis and Validation of CD4-mimetic Small Molecule Inhibitors of HIV-1 Entry: Conversion of a Viral Entry Agonist to an Antagonist. Courter, J.R., N. Madani, J. Sodroski, A. Schon, E. Freire, P.D. Kwong, W.A. Hendrickson, I.M. Chaiken, J.M. LaLonde, and A.B. Smith. Accounts of Chemical Research, 2014. 47(4): p. 1228-1237. ISI[000334658200025].

[WOS]. HIV_0523-060514.

33. Neutralising Properties of Peptides Derived from CXCR4 Extracellular Loops Towards CXCL12 Binding and HIV-1 Infection. Chevigne, A., V. Fievez, M. Szpakowska, A. Fischer, M. Counson, J.M. Plesseria, J.C. Schmit, and S. Deroo. Biochimica et Biophysica Acta-Molecular Cell Research, 2014. 1843(5): p. 1031-1041. ISI[000334476700021].

[WOS]. HIV_0523-060514.

34. Synthesis, Molecular Docking and Antiviral Screening of Novel N'-substitutedbenzylidene-2-(4-methyl-5,5-dioxido-3-phenylbenzo-E-pyrazo-lo-4,3-C 1,2 thiazin-1(4h)-yl)acetohydrazides. Aslam, S., M. Ahmad, M.M. Athar, U.A. Ashfaq, J.M. Gardiner, C. Montero, M. Detorio, M. Parvez, and R.F. Schinazi. Medicinal Chemistry Research, 2014. 23(6): p. 2930-2946. ISI[000334184400023].

[WOS]. HIV_0523-060514.

35. Annual Variation in Composition Andin Vitro anti-HIV-1 Activity of the Sulfated Glucuronogalactan Fromschizymenia dubyi (Rhodophyta, Gigartinales). Bourgougnon, N., M. Lahaye, B. Quemener, J. Chermann, M. Rimbert, M. Cormaci, G. Furnari, and J. Kornprobst. Journal of Applied Phycology, 1996. 8(2): p. 155-161. ISI[A1996VP07400009]

[WOS] HIV_0523-060514.

Patent Citations

36. Therapeutic Application of Cembranoids against HIV Replication, HIV-associated Neurocognitive Disorders and HIV-induced Inflammation. Ferchmin, P.A., V.A. Eterovic, J.W. Rodriguez, E.O. Rios-Olivares, and A.H.B. Martins. Patent. 2014. 2012-13649828 20140107225: 18pp.

[Patent]. HIV_0523-060514.

37. Novel anti-HIV Compounds. Franck, P., J. Heeres, B. Maes, S. Sergueev, and P.J. Lewi. Patent. 2014. 2013-EP73288 2014072419: 48pp.

[Patent]. HIV_0523-060514.

38. Compounds for Treating HIV and Methods for Using the Compounds Capable of Inhibiting Nef Function. Smithgall, T.E., L.A. Emert-Sedlak, B.W. Day, J. Zhao, and P.C. Iyer. Patent. 2014. 2013-US68791 2014074628: 124pp.

[Patent]. HIV_0523-060514.